El contenido de esta página de información sobre enfermedades animales y sus tratamientos está reservado a los veterinarios.
Si no eres veterinario, debes pedirle consejo a un veterinario
para cualquier pregunta que tengas sobre las enfermedades
de los animales y sus tratamientos.
Inactivated vaccine against porcine parvovirus as suspension for injection
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
|Active ingredient(s)||Route of administration||Waiting time||Packaging|
Inactivated Porcine Parvovirus, Strain NADL-8
10 ml (5 doses)
20 ml (10 doses)
50 mL (25 doses)
100 mL (50 doses)
250 mL (125 doses)
Mexico, Spain, Thailand.
If your country is not listed, please contact our export team.
Inactivated Porcine Parvovirus Strain NADL-8 >1280 HI *
* Titre of haemagglutination inhibition antibodies in guinea pig.
For active immunisation of pigs against parvovirus.
Onset of immunity: 3 weeks after primary vaccination.
Duration of immunity: 3 months after primary vaccination.
Shake the medicine before use.
Before use, allow the vaccine to reach room temperature.
The applicable dose will be 2 ml per animal in all cases, administered by intramuscular injection.
FEMALES: two vaccinations 4 weeks apart, at 6-7 months of age, which is when potential maternal antibodies will have disappeared. A minimum of 2 weeks (preferably 4) should be left between the last injection and subsequent mating.
Revaccinate 2-4 weeks before each new mating
MALES: two vaccinations 4 weeks apart, at 8 months of age.
Revaccinate every 6 months
Containers with 100 ml (50 doses).
With veterinary prescription.
Registry no.: 2910 ESP